Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2020	$ 14	$ 190,529	$ 93,778,591	$ (92,266,764)	$ 1,702,370
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320
RSU restricted Stock		$ 31	4,519		4,550
RSU restricted Stock (in Shares)		31,250
Stock-based compensation			170,029		170,029
Common stock issued on cashless exercise of options and warrant		$ 1,006	(1,006)
Common stock issued on cashless exercise of options and warrant (in Shares)		1,005,682
Common stock issued on exercise of options and warrant		$ 600	41,400		42,000
Common stock issued on exercise of options and warrant (in Shares)		600,000
Common stock issued on exercise of convertible note		$ 158	47,340		47,498
Common stock issued on exercise of convertible note (in Shares)		158,329
Sale of common stock		$ 7,056	2,250,944		2,258,000
Sale of common stock (in Shares)		7,056,250
Net loss				(1,086,438)	(1,086,438)
Balance at Mar. 31, 2021	$ 14	$ 199,380	96,291,817	(93,353,202)	3,138,010
Balance (in Shares) at Mar. 31, 2021	13,602	199,380,821
Balance at Dec. 31, 2020	$ 14	$ 190,529	93,778,591	(92,266,764)	1,702,370
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320
Net loss					(2,311,798)
Balance at Jun. 30, 2021	$ 14	$ 200,090	96,638,926	(94,578,562)	2,260,468
Balance (in Shares) at Jun. 30, 2021	13,602	200,090,572
Balance at Mar. 31, 2021	$ 14	$ 199,380	96,291,817	(93,353,202)	3,138,010
Balance (in Shares) at Mar. 31, 2021	13,602	199,380,821
Stock-based compensation			318,818		318,818
Common stock issued on cashless exercise of options and warrant		$ 260	(260)
Common stock issued on cashless exercise of options and warrant (in Shares)		259,741
Common stock issued on exercise of options and warrant		$ 450	28,550		29,000
Common stock issued on exercise of options and warrant (in Shares)		450,010
Net loss				(1,225,360)	(1,225,360)
Balance at Jun. 30, 2021	$ 14	$ 200,090	96,638,926	(94,578,562)	2,260,468
Balance (in Shares) at Jun. 30, 2021	13,602	200,090,572
Balance at Dec. 31, 2021	$ 14	$ 207,562	100,452,862	(97,692,217)	2,968,221
Balance (in Shares) at Dec. 31, 2021	13,602	207,562,461
RSU restricted Stock		$ 130	(130)
RSU restricted Stock (in Shares)		130,417
Stock-based compensation			554,877		554,877
Net loss				(1,781,190)	(1,781,190)
Balance at Mar. 31, 2022	$ 14	$ 207,692	101,007,609	(99,473,407)	1,741,908
Balance (in Shares) at Mar. 31, 2022	13,602	207,692,878
Balance at Dec. 31, 2021	$ 14	$ 207,562	100,452,862	(97,692,217)	2,968,221
Balance (in Shares) at Dec. 31, 2021	13,602	207,562,461
Sale of common stock (in Shares)		158,329
Net loss					(3,338,732)
Balance at Jun. 30, 2022	$ 14	$ 207,792	101,470,017	(101,030,949)	646,874
Balance (in Shares) at Jun. 30, 2022	13,602	207,792,878
Balance at Mar. 31, 2022	$ 14	$ 207,692	101,007,609	(99,473,407)	1,741,908
Balance (in Shares) at Mar. 31, 2022	13,602	207,692,878
Stock-based compensation			449,508		449,508
Common stock issued on exercise of option		$ 100	12,900		13,000
Common stock issued on exercise of option (in Shares)		100,000
Net loss				(1,557,542)	(1,557,542)
Balance at Jun. 30, 2022	$ 14	$ 207,792	$ 101,470,017	$ (101,030,949)	$ 646,874
Balance (in Shares) at Jun. 30, 2022	13,602	207,792,878